{"organizations": [], "uuid": "68c3995cd737fd11275cbc1a164b195ac6ae5188", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/09/globe-newswire-summit-therapeutics-provides-notice-of-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-31-january-2018.html", "country": "US", "domain_rank": 767, "title": "Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.371, "site_type": "news", "published": "2018-04-09T18:01:00.000+03:00", "replies_count": 0, "uuid": "68c3995cd737fd11275cbc1a164b195ac6ae5188"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/09/globe-newswire-summit-therapeutics-provides-notice-of-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-31-january-2018.html", "ord_in_thread": 0, "title": "Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018", "locations": [], "entities": {"persons": [{"name": "duchenne", "sentiment": "none"}], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "cambridge", "sentiment": "none"}, {"name": "oxford", "sentiment": "none"}, {"name": "united kingdom", "sentiment": "none"}], "organizations": [{"name": "smmt", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "OXFORD, United Kingdom and CAMBRIDGE, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT) will announce its financial results for the fourth quarter and fiscal year ended 31 January 2018 on 11 April 2018.\nSummit will host a conference call and webcast the same day to discuss its operational progress at 1:00pm BST / 8:00am EDT. Conference call and webcast information will be included in the full year results press release. A replay of the call will also be available through the Company's website, www.summitplc.com , shortly after its conclusion.\nAbout Summit Therapeutics\nSummit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).\nFor more information, please contact:\nSummit Glyn Edwards / Richard Pye (UK office) Tel: 44 (0)1235 443 951 Erik Ostrowski / Michelle Avery (US office) +1 617 225 4455 Cairn Financial Advisers LLP (Nominated Adviser) Tel: +44 (0)20 7213 0880 Liam Murray / Tony Rawlinson N+1 Singer (Joint Broker) Tel: +44 (0)20 7496 3000 Aubrey Powell / Jen Boorer Panmure Gordon (Joint Broker) Tel: +44 (0)20 7886 2500 Freddy Crossley, Corporate Finance Tom Salvesen, Corporate Broking MacDougall Biomedical Communications (US) Tel: +1 781 235 3060 Karen Sharma ksharma@macbiocom.com Consilium Strategic Communications (UK) Tel: +44 (0)20 3709 5700 Mary-Jane Elliott / Jessica Hodgson / summit@consilium-comms.com Philippa Gardner / Rosie Phillips -END-\nSource:Summit Therapeutics plc", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/879c06fb-4e94-44b6-8bee-70d317637a3f", "https://www.globenewswire.com/Tracker?data=xja_riivvHSyV7_9kYTHJo_ZblDNSqPlrOZc2_Dpe3f3V7bF0yJpK3VmOaZSDq6tN1j5aKpnCip9ZE2bXxtABA==", "https://www.globenewswire.com/Tracker?data=xja_riivvHSyV7_9kYTHJuZdIDzUFMc6SF1Q2Btxkf8TV84FQ1eHYyayzvZ9SMSQnKkNQc1bRU0qry70szIckg=="], "published": "2018-04-09T18:01:00.000+03:00", "crawled": "2018-04-09T18:28:25.050+03:00", "highlightTitle": ""}